$BIAF Income Statement | Understand Stock

$BIAF

$2.83 +$0.03 (1.07%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022
Patient services fees
Cost of sales
Gross profit
Operating expenses:
Direct costs and expenses
Research and development
Clinical development
Selling, general and administrative
Depreciation and amortization
Total operating expenses
Loss from operations
Other income (expense):
Interest income
Interest expense
Other income
Other expense
Gain on extinguishment of debt
Fair value of warrants issued
Fair value adjustments on convertible notes payable
Change in fair value of warrants issued
Loss before income tax expense

Income tax expense
Net loss
Net loss per common share, basic
Net loss per common share, diluted
Weighted average common shares outstanding, basic
Weighted average common shares outstanding, diluted

Comments